• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • AI SuperconnectorNEW
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • AI SuperconnectorNEW
  • Settings
  • RSS Feeds
PublishGo to AppAI Superconnector
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEW
    Legal
    Terms of usePrivacy policyCookie policy

    Cognyte Elects Two New Board Members to Strengthen Expertise and Drive Growth

    2/18/25 8:00:00 AM ET
    $ALLT
    $BLRX
    $CGEN
    $CGNT
    Computer Communications Equipment
    Telecommunications
    Biotechnology: Pharmaceutical Preparations
    Health Care
    Get the next $ALLT alert in real time by email

    Announcement reflects company's commitment to augment Board of Directors with industry-experienced executives from both the government and software sectors

    Cognyte Software Ltd. (NASDAQ:CGNT) ("Cognyte"), a global leader in investigative analytics software, today announced the appointment of two new members to its Board of Directors. Matthew O'Neill and Nurit Benjamini will join the board on March 1, 2025, and March 31, 2025, respectively, reflecting the company's commitment to add independent directors from the government and software sectors. Richard Nottenburg will be stepping down from his board position effective March 31, 2025.

    Having served with the United States Secret Service for over two decades, Mr. O'Neill brings significant law enforcement, government, financial crimes and security experience, along with established relationships within these communities. Ms. Benjamini has more than 20 years of experience as CFO in leading software companies, overseeing financial reporting for a diverse group of U.S.-listed technology firms. Together, these two directors are well-aligned with Cognyte's strategic goals of growing its business and expanding its North American presence.

    "We are pleased to welcome Matthew O'Neill and Nurit Benjamini as our two newest board members," said Earl Shanks, Chairman of Cognyte's Board of Directors. "These latest appointments reflect our commitment to further strengthen the board with deep industry and business experience. Matthew brings significant domain expertise in security and a strong understanding of U.S. federal agency practices and procedures. Nurit has extensive experience working in the software sector, where she has led finance, operations, legal and strategic initiatives across different roles and domains. We are excited to have both Matthew and Nurit with us as we continue to drive consistent long-term growth at Cognyte."

    "We sincerely appreciate Richard's valuable contributions and guidance during his tenure on the Cognyte board," added Mr. Shanks. "Richard played a key role in establishing Cognyte as an independent company with market leading technology and a solid foundation for sustainable growth."

    Mr. O'Neill served until December 2023 as the Deputy Special Agent in Charge of Cyber Operations at the United States Secret Service, where he directed the agency's global cyber investigative strategies and oversaw efforts to dismantle transnational criminal networks. During his tenure, he served as the Director of the Asset Forfeiture Branch and as the Director of the Global Investigative Operations Center, where he established the Secret Service's first agencywide criminal investigative fusion center. Mr. O'Neill holds certifications from Carnegie Mellon University and American University and earned his Bachelor of Science degree from James Madison University. He currently serves as Co-Founder and Partner at 5OH Consulting LLC.

    Ms. Benjamini is a Partner and CFO at F2 Venture Capital, bringing over 20 years of experience as a CFO for leading software companies, including CrazyLabs Ltd., Wix (NASDAQ:WIX), CopperGate Communications Ltd. and Compugen (NASDAQ:CGEN). Throughout her career, Ms. Benjamini has played a pivotal role in leading technology companies through fundraising, M&A and IPO processes. Currently, she serves as an external director at Caesarstone Ltd. (NASDAQ:CSTE), having previously served as a board member of BioLineRx (NASDAQ:BLRX) and Allot Ltd. (NASDAQ:ALLT). Ms. Benjamini holds a Bachelor of Arts degree in economics and business and a Master of Business Administration degree in finance, both from Bar Ilan University, Israel.

    About Cognyte Software Ltd.

    Cognyte Software Ltd. is a global leader in investigative analytics software that empowers a variety of government and other organizations with Actionable Intelligence for a Safer World™. Our open interface software is designed to help customers accelerate and improve the effectiveness of investigations and decision-making. Hundreds of customers rely on our solutions to accelerate and conduct investigations and derive insights, with which they identify, neutralize, and tackle threats to national security and address different forms of criminal and terror activities. Learn more at www.cognyte.com.

    View source version on businesswire.com: https://www.businesswire.com/news/home/20250218582211/en/

    Investor Relations Contact:

    Dean Ridlon

    Cognyte Software

    [email protected]

    Get the next $ALLT alert in real time by email

    Crush Q3 2025 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $ALLT
    $BLRX
    $CGEN
    $CGNT

    CompanyDatePrice TargetRatingAnalyst
    Wix.com Ltd.
    $WIX
    6/16/2025$216.00Equal Weight → Overweight
    Wells Fargo
    Wix.com Ltd.
    $WIX
    5/23/2025$190.00Neutral → Outperform
    Robert W. Baird
    Wix.com Ltd.
    $WIX
    4/8/2025$176.00Underweight → Equal Weight
    Wells Fargo
    Caesarstone Ltd.
    $CSTE
    3/6/2025Buy → Speculative Buy
    The Benchmark Company
    Wix.com Ltd.
    $WIX
    3/5/2025$250.00Sector Outperform
    Scotiabank
    Wix.com Ltd.
    $WIX
    2/3/2025$208.00Underweight
    Wells Fargo
    Wix.com Ltd.
    $WIX
    1/21/2025$225.00 → $300.00Outperform → Strong Buy
    Raymond James
    Compugen Ltd.
    $CGEN
    1/13/2025$4.00Outperform
    Oppenheimer
    More analyst ratings

    $ALLT
    $BLRX
    $CGEN
    $CGNT
    FDA approvals

    Live FDA approvals issued by the Food and Drug Administration and FDA breaking news

    View All

    FDA Approval for APHEXDA issued to BIOLINERX, LTD.

    Submission status for BIOLINERX, LTD.'s drug APHEXDA (ORIG-1) with active ingredient MOTIXAFORTIDE has changed to 'Approval' on 09/08/2023. Application Category: NDA, Application Number: 217159, Application Classification: Type 1 - New Molecular Entity

    9/11/23 2:15:50 PM ET
    $BLRX
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $ALLT
    $BLRX
    $CGEN
    $CGNT
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Wix.com upgraded by Wells Fargo with a new price target

    Wells Fargo upgraded Wix.com from Equal Weight to Overweight and set a new price target of $216.00

    6/16/25 7:44:13 AM ET
    $WIX
    Computer Software: Programming Data Processing
    Technology

    Wix.com upgraded by Robert W. Baird with a new price target

    Robert W. Baird upgraded Wix.com from Neutral to Outperform and set a new price target of $190.00

    5/23/25 8:14:47 AM ET
    $WIX
    Computer Software: Programming Data Processing
    Technology

    Wix.com upgraded by Wells Fargo with a new price target

    Wells Fargo upgraded Wix.com from Underweight to Equal Weight and set a new price target of $176.00

    4/8/25 9:19:12 AM ET
    $WIX
    Computer Software: Programming Data Processing
    Technology

    $ALLT
    $BLRX
    $CGEN
    $CGNT
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Large owner Topline Capital Partners, Lp bought $6,114,211 worth of shares (969,631 units at $6.31), increasing direct ownership by 12% to 9,020,184 units (SEC Form 4)

    4 - Cognyte Software Ltd. (0001824814) (Issuer)

    9/12/24 6:40:00 PM ET
    $CGNT
    Computer Software: Prepackaged Software
    Technology

    See Explanation in Footnotes Topline Capital Management, Llc bought $6,114,211 worth of shares (969,631 units at $6.31) (SEC Form 4)

    4 - Cognyte Software Ltd. (0001824814) (Issuer)

    9/12/24 6:31:23 PM ET
    $CGNT
    Computer Software: Prepackaged Software
    Technology

    $ALLT
    $BLRX
    $CGEN
    $CGNT
    SEC Filings

    View All

    SEC Form SCHEDULE 13G filed by BioLineRx Ltd.

    SCHEDULE 13G - BioLineRx Ltd. (0001498403) (Subject)

    8/14/25 4:03:45 PM ET
    $BLRX
    Biotechnology: Pharmaceutical Preparations
    Health Care

    SEC Form 6-K filed by BioLineRx Ltd.

    6-K - BioLineRx Ltd. (0001498403) (Filer)

    8/14/25 7:10:33 AM ET
    $BLRX
    Biotechnology: Pharmaceutical Preparations
    Health Care

    SEC Form 6-K filed by Allot Ltd.

    6-K - Allot Ltd. (0001365767) (Filer)

    8/14/25 6:02:54 AM ET
    $ALLT
    Computer Communications Equipment
    Telecommunications

    $ALLT
    $BLRX
    $CGEN
    $CGNT
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Large owner Topline Capital Partners, Lp bought $6,114,211 worth of shares (969,631 units at $6.31), increasing direct ownership by 12% to 9,020,184 units (SEC Form 4)

    4 - Cognyte Software Ltd. (0001824814) (Issuer)

    9/12/24 6:40:00 PM ET
    $CGNT
    Computer Software: Prepackaged Software
    Technology

    See Explanation in Footnotes Topline Capital Management, Llc bought $6,114,211 worth of shares (969,631 units at $6.31) (SEC Form 4)

    4 - Cognyte Software Ltd. (0001824814) (Issuer)

    9/12/24 6:31:23 PM ET
    $CGNT
    Computer Software: Prepackaged Software
    Technology

    New insider Topline Capital Management, Llc claimed ownership of 8,050,553 shares (SEC Form 3)

    3 - Cognyte Software Ltd. (0001824814) (Issuer)

    9/12/24 5:28:24 PM ET
    $CGNT
    Computer Software: Prepackaged Software
    Technology

    $ALLT
    $BLRX
    $CGEN
    $CGNT
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    BioLineRx Reports Second Quarter 2025 Financial Results and Provides Corporate Update

    - Reports continued progress in the evaluation of assets for potential pipeline expansion in the areas of oncology and rare disease; transaction targeted for 2025 -- Provides updated and extended cash runway guidance into H1 2027 -- Management to host conference call today, August 14th, at 8:30 am EDT - TEL AVIV, Israel, Aug. 14, 2025 /PRNewswire/ -- BioLineRx Ltd. (NASDAQ:BLRX) (TASE: BLRX), a development stage biopharmaceutical company pursuing life-changing therapies in oncology and rare diseases, today reported its unaudited financial results for the quarter ended June 30, 2025, and provided a corporate update. "Since our last quarterly update, we have been acutely focused on evaluating

    8/14/25 7:00:00 AM ET
    $BLRX
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Allot Announces Second Quarter 2025 Financial Results

    Exceptionally strong 73% year-over-year growth in SECaaS ARR; raising full year guidance HOD HASHARON, Israel, Aug. 14, 2025 /PRNewswire/ -- Allot Ltd. (NASDAQ:ALLT) (TASE: ALLT), a leading global provider of innovative network intelligence and security solutions for service providers and enterprises worldwide, today announced its unaudited financial results for the second quarter 2025. Financial Highlights for the Second Quarter of 2025 Revenues of $24.1 million, up 9% year-over-year with SECaaS representing 27% of overall revenue;June 2025 SECaaS ARR* of $25.2 million, up 73% year-over-year;GAAP operating loss of $0.4 million versus $3.4 million operating loss last year;Non-GAAP operating

    8/14/25 6:30:00 AM ET
    $ALLT
    Computer Communications Equipment
    Telecommunications

    Wix Announces $200 Million Increase to Share Repurchase Program

    Wix.com Ltd. (NASDAQ:WIX) ("Wix," the "Company," "we" or "our") today announced that its Board of Directors (the "Board") has authorized an increase to its program to repurchase the Company's securities (ordinary shares and/or convertible notes) by an additional amount of $200 million, subject to the satisfaction of Israeli law requirements, and other market conditions, including capital availability. To the extent these and other terms are fulfilled, together with the previously authorized $400 million out of which $100 million has been utilized, the aggregate amount available under the repurchase program will be up to $500 million. Since the beginning of 2025, the Company has repurchased $

    8/11/25 8:30:00 AM ET
    $WIX
    Computer Software: Programming Data Processing
    Technology

    $ALLT
    $BLRX
    $CGEN
    $CGNT
    Financials

    Live finance-specific insights

    View All

    BioLineRx Reports Second Quarter 2025 Financial Results and Provides Corporate Update

    - Reports continued progress in the evaluation of assets for potential pipeline expansion in the areas of oncology and rare disease; transaction targeted for 2025 -- Provides updated and extended cash runway guidance into H1 2027 -- Management to host conference call today, August 14th, at 8:30 am EDT - TEL AVIV, Israel, Aug. 14, 2025 /PRNewswire/ -- BioLineRx Ltd. (NASDAQ:BLRX) (TASE: BLRX), a development stage biopharmaceutical company pursuing life-changing therapies in oncology and rare diseases, today reported its unaudited financial results for the quarter ended June 30, 2025, and provided a corporate update. "Since our last quarterly update, we have been acutely focused on evaluating

    8/14/25 7:00:00 AM ET
    $BLRX
    Biotechnology: Pharmaceutical Preparations
    Health Care

    BioLineRx to Report Second Quarter 2025 Results on August 14, 2025

    Management to Hold Conference Call at 8:30 a.m. EDT TEL AVIV, Israel, Aug. 7, 2025 /PRNewswire/ -- BioLineRx Ltd. (NASDAQ:BLRX) (TASE: BLRX), a development stage biopharmaceutical company pursuing life-changing therapies in oncology and rare diseases, today announced that it will release its unaudited financial results for the second quarter ended June 30, 2025 on Thursday, August 14, 2025, before the U.S. markets open. The Company will host a conference call at 8:30 a.m. EDT featuring remarks by Philip Serlin, Chief Executive Officer. To access the conference call, please dial +1-888-281-1167 from the U.S. or +972-3-918-0685 internationally. A live webcast and a replay of the call can be a

    8/7/25 7:00:00 AM ET
    $BLRX
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Caesarstone Reports Second Quarter 2025 Financial Results

    - Revenue of $101.1 Million - - Gross Margin of 19.6% - Caesarstone Ltd. (NASDAQ:CSTE), a leading developer and manufacturer of high-quality engineered surfaces, today reported financial results for its second quarter ended June 30, 2025. Yos Shiran, Caesarstone's Chief Executive Officer commented, "We are taking decisive action to align our cost structure to improve profitability at current revenue levels. During the quarter, we approved cost reduction measures expected to generate an additional $10 million of annualized savings, commencing in the second half of 2025. We also continued to benefit from an improved production footprint. In addition, we remain focused on investing in ou

    8/6/25 7:00:00 AM ET
    $CSTE
    Building Materials
    Industrials

    $ALLT
    $BLRX
    $CGEN
    $CGNT
    Leadership Updates

    Live Leadership Updates

    View All

    PayPal and Wix Advance Strategic Relationship to Deliver Unified Payments Experience for Merchants

    PayPal integrates with Wix Payments, providing a consolidated view for merchants to streamline payment management, enhance conversions and meet growing demand for flexible payment options  NEW YORK – Wix.com Ltd. (NASDAQ:WIX), the leading SaaS website builder platform globally1, today announced an expansion of its partnership with PayPal Holdings Inc. (NASDAQ:PYPL), bringing additional online payment options to merchants through Wix Payments. Now available as a built-in part of Wix Payments, this provides U.S.-based merchants a unified, seamless experience that simplifies backend operations and ultimately supports higher checkout conversion.  With this deeper integration, PayPal is now ava

    7/24/25 9:00:00 AM ET
    $PYPL
    $WIX
    Diversified Commercial Services
    Industrials
    Computer Software: Programming Data Processing
    Technology

    Cognyte Appoints Distinguished Innovator Ronny Lempel as Chief Technology Officer to Guide AI-Focused Research

    25+ years of technology expertise and leadership will continue to cultivate innovation for sustained company growth Cognyte Software Ltd. (NASDAQ:CGNT) ("Cognyte"), a global leader in investigative analytics software, today announced the appointment of Dr. Ronny Lempel as Chief Technology Officer (CTO). In this role, Lempel will apply over 25 years of proven, cross-discipline technology expertise to extend Cognyte's innovation leadership and bring unparalleled vision and value to Cognyte's customers. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250318301357/en/Cognyte appointed Dr. Ronny Lempel as Chief Technology Officer (CTO

    3/18/25 8:00:00 AM ET
    $CGNT
    Computer Software: Prepackaged Software
    Technology

    Cognyte Elects Two New Board Members to Strengthen Expertise and Drive Growth

    Announcement reflects company's commitment to augment Board of Directors with industry-experienced executives from both the government and software sectors Cognyte Software Ltd. (NASDAQ:CGNT) ("Cognyte"), a global leader in investigative analytics software, today announced the appointment of two new members to its Board of Directors. Matthew O'Neill and Nurit Benjamini will join the board on March 1, 2025, and March 31, 2025, respectively, reflecting the company's commitment to add independent directors from the government and software sectors. Richard Nottenburg will be stepping down from his board position effective March 31, 2025. Having served with the United States Secret Service f

    2/18/25 8:00:00 AM ET
    $ALLT
    $BLRX
    $CGEN
    Computer Communications Equipment
    Telecommunications
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $ALLT
    $BLRX
    $CGEN
    $CGNT
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    SEC Form SC 13G filed by Allot Ltd.

    SC 13G - Allot Ltd. (0001365767) (Subject)

    11/18/24 9:00:22 AM ET
    $ALLT
    Computer Communications Equipment
    Telecommunications

    Amendment: SEC Form SC 13G/A filed by Caesarstone Ltd.

    SC 13G/A - Caesarstone Ltd. (0001504379) (Subject)

    11/14/24 6:21:59 AM ET
    $CSTE
    Building Materials
    Industrials

    Amendment: SEC Form SC 13G/A filed by Cognyte Software Ltd.

    SC 13G/A - Cognyte Software Ltd. (0001824814) (Subject)

    11/12/24 4:07:25 PM ET
    $CGNT
    Computer Software: Prepackaged Software
    Technology